Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV)

Completed · Phase 2 · Has a placebo group

Conditions studied: Bacterial Vaginosis

In brief

The purpose of this study is to determine the efficacy of SPL7013 Gel in the treatment of bacterial vaginosis.

Key facts

Study ID

NCT01201057

Run by

Starpharma Pty Ltd

People needed

132

Starts

2010-08-01

Expected to finish

2011-05-01

Last updated by the study team

2019-06-06

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women aged 18-45 years with a diagnosis of BV according to Amsel's criteria and a Nugent score of ≥4
• Otherwise healthy

You may not qualify if…

• No active STIs

Where it is running

• Precision Trials — Phoenix, Arizona, United States
• Downtown Women's Health Care — Denver, Colorado, United States
• Clinical Research Center of Nevada — Las Vegas, Nevada, United States
• Bexar Clinical Trials, LLC — Irving, Texas, United States
• Tidewater Clinical Research Inc — Virginia Beach, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.